Katherine Wilemon of the Family Heart Foundation discusses the need for Lp(a) screening in the US, where rates are historically low despite risk.
Katherine Wilemon
Advertisement
Katherine Wilemon, CEO, Family Heart Foundation.
Articles by Katherine Wilemon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
2
FDA Panel Backs 6 Peptides for Compounding
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Boston Panel Confronts Access and Coordination Gaps in Obesity Care
5